Innovative Technique Produces More Reliable Pluripotent Stem Cells
By LabMedica International staff writers
Posted on 02 Oct 2014
A recent paper described a more reliable way to induce the formation of pluripotent stem cells (iPSCs) from adult cells in a mouse model.Posted on 02 Oct 2014
Reliable high-quality iPSCs are needed for the development of therapeutic applications. Induced pluripotent stem cells are commonly generated by transduction of the "OSKM" genes into cells for the production of the reprogramming factors Oct4 (octamer-binding transcription factor 4), Sox2 (sex determining region Y)-box 2), Klf4 (Krueppel-like factor 4), and Myc (v-myc myelocytomatosis viral oncogene homolog protein). Although such iPSCs are pluripotent, they frequently exhibit high variation in terms of quality, as measured in mice by chimera contribution and tetraploid complementation.
Image: A scheme for the generation of induced pluripotent stem cells (IPSC). (1) Isolate and culture donor cells. (2) Transfect stem cell-associated genes into the cells by viral vectors. Red cells indicate the cells expressing the exogenous genes. (3) Harvest and culture the cells using mitotically inactivated feeder cells. (4) A small subset of the transfected cells forms iPSC cell colonies (Photo courtesy of Wikimedia Commons).
Investigators at the Hebrew University of Jerusalem (Israel) used bioinformatic analysis to design a new formulation of transducer genes that generated high-quality iPSCs more efficiently than other combinations of factors including OSKM. The new cocktail of reprogramming factors (SNEL) included Sall4 (Sal-like protein 4), Nanog (Nanog homeobox), Esrrb (Estrogen-related receptor beta), and Lin28 (Lin-28 homolog A).
The new SNEL cocktail created fewer iPSC colonies than the traditional OSKM approach, but approximately 80% of those produced passed the most stringent pluripotency tests. This is preferable to the OSKM method, which produces a large number of colonies, but the majority of which fail the pluripotency tests.
First author Dr. Yossi Buganim, a postdoctoral researcher in developmental biology at the Hebrew University of Jerusalem, said, "SNEL may reprogram cells better than OSKM because it does not rely on the master regulators Oct4 and Sox2, which might activate part of the adult cell genome. This research demonstrates the effectiveness of bioinformatics tools in producing high quality iPSCs."
Related Links:
Hebrew University of Jerusalem